◆ 会议时间：2027年
◆ 会议地点：TBD


◆ 会议简介：

2027年美国肾脏病学会年会——美国肾脏周(ASN Kidney Week 2027)将于2027年举行，会议由美国肾脏病学会(ASN)主办。美国肾脏病年会ASN肾脏周是国际上规模最大、学术水平最高的肾脏病学术盛会，预计有来自世界各地的13000余名专业人士参加本次会议。

美国肾脏病学会（ASN）成立于1966年，是世界上最大的致力于肾脏疾病研究的专业学会，在全球132个国家/地区宣拥有21,240余名成员。ASN愿景是预防、治疗和治愈肾脏疾病（未经许可，禁止复制摘录转载本站任何内容-领域国际医学会议网）。

ASN Kidney Week 2027

THE WORLD'S PREMIER NEPHROLOGY MEETING
Join ASN and more than 13,000 other kidney professionals from across the globe at Kidney Week 2027. The world's premier nephrology meeting, Kidney Week provides participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field.

以下为往届会议信息，仅供参考！

摘要提交：

Kidney Week 2021: Call for Abstracts

点此提交摘要>>>Submit Abstract>>>

摘要提交教程>>>Abstract submission tutorial>>>

提交日期：

ASN will accept submissions for research abstracts and clinical case reports electronically from April 14, 2021 through June 2, 2021 (2:00 p.m. EDT)

A late-breaking clinical trial (LBCT) abstract is a synopsis of the most important information from a significant scientific study that has just concluded, is of high-impact to the nephrology community, or has crucial data that was not available in time for the regular abstract submission cycle. Only phase II and III clinical trials abstracts will be accepted, and preference will be given to those with final study results submitted. The LBCT submission site opens on July 14, 2021 and closes on September 1, 2021 at 2:00 p.m. EDT.

摘要提交资格：

Nonmembers can submit abstracts without ASN member sponsorship.
All authors must have ASN records
All authors must have current disclosures on file with ASN

摘要提交数量与提交费：

There is no limit to the number of research abstracts that an individual may submit. There is a limit of 2 clinical case reports per first author (presenting author). The $70 processing fee per submission is nonrefundable. The processing fee must be paid at the time of submission by credit card (American Express, MasterCard, or VISA).

摘要提交字数要求：

An abstract submission may contain a maximum of 2,500 characters, and the count includes characters and spaces in the following: Authors Names, Title, Body, Figure, and Table. Up to 2 figures and 1 table can be included in a submission. Figure count is determined by image height but will not exceed 560 characters. Table count is 50 characters per row. Please note that Author Institutions do not count towards the character count.

摘要提交准则：

• All types of nephrology-related research are eligible for submission and should address scientific questions, detail clinical observations, or contain preliminary scientific data.
• Abstracts are NOT eligible for consideration if the research will have been presented (oral or poster) at another meeting or press conference prior to Kidney Week.
• Abstracts are NOT eligible for consideration if the research has been published or accepted for publication by June 2, 2021.
• Posting of un-refereed manuscripts to a community preprint server by authors will not be considered prior publication, provided that the following conditions are met:
  • During submission, authors must acknowledge preprint server deposition.
  • Versions of a manuscript that have been altered as a result of the peer review process may not be deposited;
  • The preprint version cannot be indexed (e.g., in MEDLINE or PubMed).
  • Upon ASN publication, authors are responsible for updating the archived preprint version with a link to the ASN Abstract Supplement PDF.
    • The preprint server should meet NIH standards for interim research product repositories.
• Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts.
• All research and studies in submitted abstracts must comply with the WMA Declaration of Helsinki, the Declaration of Istanbul on Organ Trafficking and Transplant Tourism, and the NIH Guide for the Care and Use of Laboratory Animals.
• Accepted abstracts may be assigned for oral presentation, assigned for poster presentation, and/or published in the ASN Abstract Supplement PDF.
• Important! If your research data are available by June 2, 2021, ASN strongly recommends that you submit your abstract during the regular call for abstracts, rather than holding it for the call for late-breaking clinical trials. The regular call for abstracts has more opportunities for oral presentations and posters than the call for late-breaking clinical trials.

• Case reports must include uniqueness of the case, clinical findings presented, outcomes documented, and "take-away" lessons (teaching points).
• There is a limit of 2 case report submissions per first author (presenting author).
• Accepted case reports may be assigned for poster presentation and/or published in the ASN Abstract Supplement PDF (generally not oral presentation).

• There will be a separate Call for Informational Posters on June 16 - July 7, 2021, 2:00 p.m. EDT.
• Submissions must include research services in core facilities at academic or nonprofit institutions as well as ongoing clinical trials open to enrollment. The purpose is to stimulate utilization of research core facilities and enrollment in clinical trials.
• Abstracts describing clinical trial results are NOT eligible for consideration.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。